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Cut-off value of D-dimer in pulmonary
thromboembolism and pneumonia
Aim: The differential diagnosis of pulmonary thromboembolism (PTE) and pneumonia remains
difficult in emergency rooms. High D-dimer levels in the pneumonia may be misdiagnosed as PTE
on the basis of similar clinical, radiological, and laboratory findings. Since D-dimer elevation may
also be seen in pneumonia cases, the comparison of D-dimer values in patients diagnosed as
pneumonia and PTE, in order to determine a cut-off value between the 2 diseases, was aimed in this
study.
Materials and methods: Patients in the community acquired pneumonia (CAP) group were classified
according to the American Thoracic Society (ATS) 2001 criteria. Groups III and IV patients, who
were hospitalized, were included in the study. The final CAP group consisted of 52 patients (30 in
Group IIIa, 15 in Group IIIb, 2 in Group IVa, and 5 in Group IVb) and 68 patients with a diagnosis
of PTE. All patients’ D-dimer levels in the first day were recorded.
Results: Mean D-dimer levels of the PTE and pneumonia group were 4868 ng/mL and 2068 ng/mL,
respectively (P < 0.001). Cut-off value was 4374 ng/mL. Mean levels of D-dimer in the massive PTE
group and sub-massive PTE group were 5438 ng/mL and 4175 ng/mL,respectively, (P = 0.04).
Conclusion: Elevation of D-dimer is more significant in PTE than pneumonia. As a result, if Ddimer level is higher than 4374 ng/mL, the patient should be evaluated for the diagnosis of PTE. A
cut-off value of 4374 ng/mL will help the discrimination of PTE and pneumonia.
Key words: Pneumonia, pulmonary embolism, D-dimer, cut-off value

Pulmoner tromboemboli ve pnömonide eşik değer olarak D-dimer
Amaç: İlk değerlendirmede Pulmoner Tromboemboli (PTE) ve pnömoni arasında ayırım yapmak zor
olabilir. D-dimer düzeyleri yüksek olan pnömoni hastaları benzer klinik, radyolojik ve laboratuar
bulgular nedeniyle PTE ile karışabilmektedir. Bu çalışmada PTE ve pnömoni hastalarının D-dimer
düzeylerini karşılaştırarak iki hastalık arasında eşik değerin bulunması amaçlandı.
Yöntem ve gereçler: Toplum Kökenli Pnömoni (TKP) tanılı hastalar American Thoracic Society
(ATS) 2001 kriterlerine göre gruplandırıldı. Buna gore hastanede yatırılırak tedavi edilen Grup III ve
IV hastalar çalışmaya alındı. TKP grubunda olan 52 hastanın (Grup IIIa: 30, Grup IIIb:15, Grup IVa:
2 ve Grup IVb: 5) ve PTE grubunda yer alan 68 hastanın başlangıç D-dimer düzeyleri kaydedildi.
Received: March 18, 2009
Accepted: August 14, 2009

Bulgular: PTE grubunda ortalama D-dimer düzeyi 4868 ng/mL; pnömoni grubunda ise 2068 ng/mL
olarak bulundu (P < 0,001). Eşik değer 4374 ng/mL olarak bulundu. Ortalama D-dimer düzeyi masif
PTE grubunda 5438 ng/mL, minör PTE grubunda ise 4175 ng/mLolarak saptandı (P = 0,04).
Sonuç: Bu çalışmada PTE grubunda D-dimer düzeyinin pnömoni grubuna göre anlamlı olarak daha
yüksek olduğu bulundu. Sonuç olarak, D-dimer düzeyi eşik değerin (4374 ng/mL) üzerindeki hastalar
PTE yönünden de değerlendirilmelidir.
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Introduction
Pulmonary thromboembolism (PTE) is a serious, life threatening condition.
In massive thromboembolic events, death might occur suddenly. Usually these
patients die before admittance to hospital (1). Early diagnosis and treatment,
particularly in suspected patients, is crucial. Therefore, D-dimer, frequently used
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as a diagnostic test, has gained an importance.
However, due to the higher D-dimer level in certain
events, such as patients who had an operation,
experienced trauma, had kidney and liver diseases,
extrapulmonary
infections,
disseminated
intravascular coagulation (DIC), and who are
pregnant, it is mostly being used for the exclusion of
PTE (2-4). Pneumonia may sometimes be
misdiagnosed on the basis of clinical, radiological,
and laboratory findings (5). Since D-dimer elevation
may also be seen in pneumonia cases, the comparison
of D-dimer values in patients diagnosed with
pneumonia and PTE in order to determine a cut-off
value between the 2 diseases was aimed in this study.
Materials and methods
A total of 52 patients with community-acquired
pneumonia (CAP) and 68 patients with PTE admitted
to the emergency department of Atatürk Training and
Research Hospital between the years 2004 and 2007
and treated at the pulmonary diseases clinic were
included in the study. This study was approved by the
ethics committee of Ankara Atatürk Training and
Research Hospital. We did not obtain patient consent
because the study is retrospective.
The mean ages of CAP and PTE groups were 60.5
± 16.7 and 57.9 ± 14.9 years, respectively. In the CAP
group, patients younger than 18 years, having
vasculitis, cancer, chronic renal and hepatic diseases,
who were pregnant, and who recently had undergone
an operation or trauma were excluded. For the PTE
group, patients under the age of 18 were excluded
from the study.
Computed tomography (CT) angiography was
performed on 68 cases, in which PTE was considered
with high clinical probability according to the Wells
score (6). The diagnosis was confirmed using
ventilation-perfusion (V/Q) scintigraphy in 13
suspected patients, who were not be able to be
diagnosed by CT angiography. A dual-detector CT
(Somatom Emotion Duo, Siemens) was used. V/Q
scintigraphy was performed via Siemens E-CAM dual
head system using Tc99macro albumin aggregate for
perfusion scintigraphy, and Tc99DTPA for ventilation
scintigraphy. PTE with medium and high probabilities
were determined in 2 and 11 patients, respectively,
based on clinical data.
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Of the 52 patients in the CAP group, 25 underwent
CT angiography for differential diagnosis, since PTE
could not be excluded through clinical findings,
physical examinations, and pulmonary X-ray
findings.
On CT angiography, thrombus that obstructed the
lumen of main pulmonary artery in more than 50%
and/or caused the obstruction of 2 or more lobar were
classified as massive emboli, whereas the others were
classified as submassive emboli (7, 8). Of the PTE
patients, 38 were massive and 30 were submassive.
Patients in the CAP group were classified
according to the American Thoracic Society (ATS2001 criteria (9). Group I and II patients, treated in
ambulatory conditions, were not included in the
study. Group III and IV patients, who were
hospitalized, were included in the study. The final
CAP group consisted of 52 patients: 30 in Group IIIa,
15 in Group IIIb, 2 in Group IVa, and 5 in Group IVb.
D-dimer levels of these patients were analyzed via
mini-VIDAS system (Biomerieux, France) using the
ELFA (enzyme linked fluorescence assay) kit on the
first day of their admission to the emergency room.
The blood samples were collected into tubes with
3.8% trisodium citrate and centrifuged at 3000 rpm
(approximately 1500g) in the laboratory. Obtained
plasma samples were rapidly transferred into plastic
tubes. For each sample, DD2 rod and DD2 SPR were
transferred into room temperature from the kit
pouch, and then placed on the VIDAS
preparation/loading tray. The plasma samples were
placed into sample holes via a pipette, with 200 μL in
each hole. After the initial stage, the equipment
automatically completed all steps within 35 min. The
results were calculated via a computer, which was
connected to the equipment, using calibration curves.
The test was repeated by diluting the plasma sample at
a ratio
of 1/5 in the presence of results higher than
4
/mL.
Values over 500 ng/mL were accepted to be
10
positive.
Statistical analysis
The results were analyzed using SPSS 11.5 The
Kolmogorov-Smirnov test revealed that the data
regarding massive embolus, submassive embolus, and
Group IIIa and IIIb pneumonia patients were
concordant with the normal distribution; however,
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the distribution of Groups IVa and IVb was not
concordant with the normal distribution. Therefore,
the differences between groups, in terms of mean
values, was compared using the Mann-Whitney U test
in Group IVa and IVb patients, whereas Student’s ttest was used in the other groups. The distribution of
gender among groups was analyzed using the Chisquare test. P < 0.05 was assumed to be the
significance level. The mean, minimum, and the
maximum values of the variables were determined.
Results
The mean ages of patients in the CAP and PTE
groups were 60.5 ± 16 and 57.9 ± 14.9 years,
respectively. The difference between the groups in
terms of mean age was not statistically significant (P
= 0.3726).
When the gender distribution among groups was
evaluated, it was observed that there were 42 (62%)
females and 26 (38%) males in the PTE group, and 20
(38%) females and 32 (62%) males in the CAP group.
The difference between the groups in terms of gender
distribution was significant (P = 0.0213). The mean
D-dimer value of all females, regardless of being in
the CAP or PTE group, was 4306 ± 2497 ng/mL,
whereas for males it was 3004 ± 2383 ng/mL.
Accordingly, D-dimer levels were found to be
significantly higher, independent of the disease,
among females compared to males (P = 0.007).
The mean D-dimer values in both PTE and CAP
groups were 4868 ± 4753 ng/mL, (minimum 852,
maximum 10,000) and 2068 ± 2031 ng/mL
(minimum 177, maximum 10000), respectively. Ddimer levels in the PTE group were found to be
significantly higher compared to the level of the CAP
group (P < 0.001) (Table 1).
The cut-off level of D-dimer between PTE and
CAP was determined as 4374 ng/mL. Receiver
Table 1.

D-dimer values of patients in the PTE and pneumonia
groups.

Disease

Mean D-dimer ± SD ng/mL

PTE

4868 ± 4753

Pneumonia

2068 ± 2031

P

<0.001
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Figure 1. D-dimer levels CAP and PTE patients.

operator characteristic curves for the cut-off value of
D-Dimer are shown in Figure 2. The specificity and
the sensitivity of D-dimer in differential diagnosis
were found to be 94.2% and 60.2%, respectively.
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Figure 2. Receiver operator characteristic curves for the cut-off
value of D-Dimer.

The D-dimer levels were less than 2000 ng/mL in
34 of the CAP cases as shown in Figure 1; however, it
was less than 2000 ng/mL in only 10 of the PTE cases.
(In 49 of the 52 CAP cases, the D-dimer level, which
was determined as 4374 ng/mL, was below the cut-off
value, whereas it was below the cut-off value in only
27 of the 68 PTE cases).
The mean D-dimer level in massive PTE and
submassive PTE groups were in turn found to be 5438
± 2588 ng/mL (minimum: 852 maximum: 10,000)
and 4175 ± 2241 ng/mL (minimum: 928 maximum:
10,000). D-dimer level was significantly higher in the
massive PTE group compared to the submassive PTE
group (P = 0.04) (Table 2).
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Table 2.

Comparison of D-dimer levels of massive and
submassive PTE cases.

Disease

Mean D-dimer ± SD ng/mL

Massive

5438 ± 2588

Submassive

4175 ± 2241

P

= 0.04

The mean D-dimer levels of the CAP groups were
as follows: 2034 ± 2349 ng/mL (minimum: 177
maximum: 10,000) in Group IIIa, 1814 ± 977 ng/mL
(minimum: 289 maximum: 3713) in Group IIIb, 2202
± 1330 ng/mL (minimum: 1262 maximum: 4248) in
Group IVa, and 2983 ± 2031 ng/mL (minimum: 811
maximum: 7535) in Group IVb.
No significant difference was determined between
Group III and Group IV (P = 0.26) (Table 3). In
addition, there was no significant difference between
Groups IIIa and IIIb, and between Groups IVa and
IVb (P = 0.71 and P = 1.00) (Table 4).

Table 3.

Comparison of D-dimer levels among pneumonia
groups 3 and 4.

Pneumonia

Mean D-dimer ± SD ng/mL

Group III

1961 ± 1988

Group IV

2760 ± 2327

P

0.26

Table 4.

Comparison of D-dimer levels among pneumonia
subgroups.

Pneumonia

Mean D-dimer ± SD ng/mL

Group IIIa

2034 ± 2349

Group IIIb

1814 ± 977

Group IVa

2202 ± 1330

Group IVb

2983 ± 2031

P

0.71

1.00

Discussion
D-dimer might elevate in certain conditions, such
as PTE, CAP, deep venous thrombosis (DVT), solid
tumors, leukemia, chronic hepatic diseases, severe
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infections, recent trauma and surgical procedures,
disseminated intravascular coagulation (DIC),
pregnancy, preeclampsia, exercise, vasculitis, sickle
cell anemia, myocardial infarction, and unstable
angina pectoris. Therefore, the sensitivity of this test
is not so high. However, generally, various authors
have shown in studies regarding D-dimer levels in
PTE that the negative predictive value of this test is
high as an exclusion test (3).
PTE and CAP can be mistaken for each other in
terms of clinical, laboratorial, and radiological
findings, particularly at the beginning. There are
studies showing that the sensitivity of pulmonary Xray is 24%, and thorax CT is 62%. Radiologically,
similar CT findings might be seen especially in nonPTE pulmonary infections (10). D-dimer, which is
used as an exclusion test, can rise in pneumonia as
well as in many other diseases (5, 11).
Different mechanisms explaining D-dimer’s
elevation in pneumonia have been proposed. D-dimer
could rise due to the enzymatic degradation and
absorption of fibrin, accumulated within alveoli as a
result of vascular congestion. The activation of
coagulation due to endotoxins in gram-negative
pneumonia and also due to necrosis resultant from
vascular damage in severe pneumonia may elevate the
D-dimer level (12, 13).
D-dimer level directly proportional to the severity
of disease has been previously observed in pneumonia
patients (5, 14). Querol-Ribelles et al. evaluated
pneumonia cases classified according to pneumonia
severity index (PSI) and Physiology and Chronic
Health Evaluation (APACHE II) score and verified an
increasing D-dimer level with the pneumonia severity
(14). Various scoring systems can be used to
determine the pneumonia severity (15). In this study,
ATS scoring was used to classify the pneumonia
patients. No significant correlation between D-dimer
and disease severity could be demonstrated. However,
the smaller number of cases in Group IV was
considered to have affected this result. In the study
carried out by Shilon et al., the possibility of
identifying disease severity in community-acquired
pneumonia by D-dimer levels was emphasized. It was
underlined that, in these patients, multi-organ failure
might occur as disease severity increases, which could
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affect the D-dimer level. Therefore, they suggested
additional studies. That study included pneumonia
groups treated in ambulatory care settings, classified
as I, II, and III according to the Pneumonia Patient
Outcomes Research Team (PORT) severity score.
(16). In this study, the relationship between the
severity of pneumonia and D-dimer could not be
properly demonstrated since we only included the
cases in Groups III and IV according to ATS, who
were receiving treatment during hospitalization.
The relationship between PTE size and D-dimer
elevation was investigated by Grau et al. They found
a 2.9-times increase in mortality risk in patients with
D-dimer level above 5000 ng/mL (17). Also in this
study, increased D-dimer level due to the size of the
embolus was observed. D-dimer level of the massive
embolus group was significantly higher than the
submassive embolus group. It was found to be 5438 ±
2588 /mL among 38 patients with massive embolus.
The relationship analysis between D-dimer and
gender, regardless of diagnosis, revealed that D-dimer
was significantly higher in females compared to males
in this study. It is being considered that hormonal
changes may affect the venous fibrinolysis in
postmenopausal women (18). However, the female
cases were not evaluated under such discrimination
in our study. Nonetheless, 50 (17 cases in pneumonia
group, 33 cases in PTE group) of the 60 female cases
were older than 50.
In a study carried out by Castro et al. and
conducted in 19 pneumonia and 52 PTE patients
diagnosed via V/Q scintigraphy, the D-dimer level
was found to be 6044 ± 4505 ng/mL in 20 patients
with high potential for PTE, and 2695 ± 2908 ng/mL
in the pneumonia group. D-dimer levels higher than
9500 ng/mL have sensitivity and specificity of 33%
and 90%, respectively. When all the PTE cases were
evaluated, no significant difference was found. The
sensitivity and the specificity were 17% and 90%,
respectively (11). In our study, which was performed
on 52 pneumonia and 68 PTE patients, the mean
plasma D-dimer level of all the PTE and pneumonia
cases was found to be 4868 ± 4753 ng/mL and 2068 ±
2031 ng/mL, respectively. The threshold value, which
might be used in differential diagnosis of PTE and

October 2009

pneumonia, was determined as 4374 ng/mL. The
sensitivity and specificity of the test in differential
diagnosis of PTE and CAP, on the basis of this
threshold value, were found to be 60.2% and 94.2%,
respectively. Even these values are higher than those
found by Castro et al.; their confidential use for
clinical differential diagnosis is controversial. It can
be considered as one of the auxiliary methods in
differential diagnosis. It is more important to
recognize that high D-dimer levels can be found in
pneumonia as well. In our study, D-dimer level was
found to be over 2000 ng/mL in 18 of the 52 cases
with pneumonia. High D-dimer levels, particularly
present in pneumonia patients with chest pain in
emergency room, may require advanced analyses,
such as CT angiography, in many patients. It has been
observed that, if the patients can be easily diagnosed
as pneumonia via clinical and radiological findings,
the use of D-dimer analysis may cause confusion.
Mikaeilli et al. pointed out that D-dimer test is useful
to show the severity of the disease in patients with
diagnosis of proven pneumonia (19). Another use of
D-dimer test may be to identify low risk patients in
community acquired pneumonia as shown in the
literature (20). D-dimer test in pneumonia patients is
responsible for over estimated PTE. PTE is a very
important disease beyond any doubt, and should be
diagnosed promptly. Likewise, pneumonia’s
complications can be prevented by early diagnosis and
appropriate antibiotherapy.
The limitation of the study is that this is a
retrospective study and we could not compare the
other biomarkers (such as C-reactive protein,
troponin-I, fibrinogen) with D-dimer to use in the
differential diagnosis of PTE and pneumonia. In case
of a high D-dimer level, a cut-off value, which can be
used at least as an auxiliary method in differential
diagnosis of these 2 diseases, will accelerate the
diagnostic process.
In the light of our results, the cut-off level
determined in this study will represent a valuable aid
for either emergency or clinical practice physicians.
By being aware of D-dimer elevation in many
conditions other than PTE, physicians will be able to
correct or avoid potential mistakes.
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